Zhengyuan Zhihui Group (300645.SZ) plans to launch a 2026 employee stock ownership plan.
Zhengyuan Zhihui (300645.SZ) has released the draft 2026 employee stock ownership plan. The employee stock ownership plan will acquire the company's A-shares that have been repurchased and are held in the special securities account for share repurchases through non-trading transfer or other methods permitted by laws and regulations, totaling no more than 1.4209 million shares, accounting for approximately 1.00% of the company's current total share capital. The transfer price is 6.62 yuan per share.
Zhengyuan Zhihui Group (300645.SZ) has released the draft of its 2026 Employee Stock Ownership Plan. The Employee Stock Ownership Plan will acquire the Company's repurchased A-share shares held in the special securities account for share repurchases through non-trading transfer or other methods permitted by laws and regulations, totaling no more than 1.4209 million shares, accounting for approximately 1.00% of the Company's current total share capital. The transfer price is RMB 6.62 per share.
The duration of this Employee Stock Ownership Plan is 48 months, and the lock-up period for the underlying shares acquired is 12 months, commencing from the date of the Company's announcement that the last batch of underlying shares has been transferred to the name of this Employee Stock Ownership Plan.
Related Articles

MTR CORPORATION (00066) accepts the HK$10.5 billion land premium offer for Phase 2 of the Tuen Mun Area 16 Station project in Hong Kong, with the land premium fully deductible.

JPMorgan increases its shareholding in Montage Technology (06809) by approximately 119,200 shares at approximately HK$274.93 per share.

Shanghai Kehua Bio-engineering (002022.SZ): Two products obtained medical device registration certificates.
MTR CORPORATION (00066) accepts the HK$10.5 billion land premium offer for Phase 2 of the Tuen Mun Area 16 Station project in Hong Kong, with the land premium fully deductible.

JPMorgan increases its shareholding in Montage Technology (06809) by approximately 119,200 shares at approximately HK$274.93 per share.

Shanghai Kehua Bio-engineering (002022.SZ): Two products obtained medical device registration certificates.

RECOMMEND





